Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

詳細情報 詳細情報について

• CRID

  1361699994428469760

• DOI

  10.1016/s1470-2045(19)30801-0

• ISSN

  14702045

• Web Site

  https://api.elsevier.com/content/article/PII:S1470204519308010?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1470204519308010?httpAccept=text/plain

• データソース種別

  • Crossref